Abstract:Accurate diagnosis of tumors and predicting the therapeutic responses are highly demanded in the clinic to improve the treatment efficacy and survival rates. Since hypoxia develops in the progression of tumors and inversely correlates with prognosis and promotes resistance to radiotherapies and immunotherapies, it is a potential marker for therapeutic prediction. Therefore, effective discrimination of tumor hypoxia for predicting therapeutic outcomes is critical. Here, a magnetic resonance imaging (MRI)-based diagnosis strategy using contrast-amplifying nanoprobes that sense tumor acidosis and real-time observation of hypoxic conditions in tumors has been developed, aiming at accurate detection of pancreatic tumors and prediction of therapeutic effects. Our approach selectively probed xenograft, allograft, and transgenic spontaneous models of intractable pancreatic cancer, which lacks standardized predictive markers to identify patients who benefit most from treatments, and effectively discriminated the intratumoral hypoxia levels. By stratification of pancreatic tumors based on quantitative MR imaging of hypoxia, it enabled prediction of the responses to radiotherapy and immune checkpoint inhibitors. Moreover, the nanoprobe-based MRI could monitor hypoxia reduction by tumor normalization treatments, which permits visualizing pancreatic tumors that will respond to immune checkpoint blockade therapy, enhancing the response rate. The results demonstrate the potential of our strategy for accurate tumor diagnosis, patient stratification, and effective therapy.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsnano.1c04263.Synthesis of PEG-b-P(Glu), stability of nanoprobes, cytotoxicity of nanoprobes, pathological confirmation of the ultrasmall and orthotopic BxPC3 pancreatic tumors after MR imaging, MR imaging and pathological confirmation of spontaneous pancreatic tumors and ovarian tumors, hypoxia staining and image of BxPC3 tumors in radiotherapy, body weight of mice in radiotherapy, hypoxia staining and analysis results of Panc02 tumors, image of Panc02 tumors and the body weight of mice in immunotherapy, analysis of M1 and M2, Tregs, hyaluronan, collagen I, and α-SMA, and tumor vasculature in Panc02 tumors, and safety evaluation (PDF)This article has not yet been cited by other publications.

Magnetic Resonance Imaging Nanoprobe Quantifies Nitric Oxide for Evaluating M1/M2 Macrophage Polarization and Prognosis of Cancer Treatments

Highly Sensitive Imaging of Tumor Metastasis Based on the Targeting and Polarization of M2-like Macrophages.

A Mitochondria-Targeted Nitric Oxide Probe for Multimodality Imaging of Macrophage Immune Responses.

Responsive Probes for in Vivo Magnetic Resonance Imaging of Nitric Oxide

A Smart Responsive Nanotheranostic System for MRI of Tumor Response to Immunotherapy and Enhanced Synergism of Thermo‐Immunotherapy

Nanoprobe-Based Magnetic Resonance Imaging of Hypoxia Predicts Responses to Radiotherapy, Immunotherapy, and Sensitizing Treatments in Pancreatic Tumors

T1/T2 Proportional Magnetic Resonance Nanoprobe Monitoring Tumor Autophagy During Chemotherapy

A Tandem‐Locked Chemiluminescent Probe for Imaging of Macrophage Polarization

Targeted Imaging of CD206 Expressing Tumor-Associated M2-like Macrophages Using Mannose-Conjugated Antibiofouling Magnetic Iron Oxide Nanoparticles.

Magnetic Nanocluster-Mediated Photothermal Effect and Macrophage Modulation for Synergistic Photothermal Immunotherapy of Cancer

Noninvasive Imaging of CD206-Positive M2 Macrophages as an Early Biomarker for Post-Chemotherapy Tumor Relapse and Lymph Node Metastasis

BODIPY-Based NO Probe for Macrophage-Targeted Immunotherapy Response Monitoring.

Surface Functionalization of Superparamagnetic Nanoparticles for the Development of Highly Efficient Magnetic Resonance Probe for Macrophages

Ph-Responsive Iron Manganese Silicate Nanoparticles As T1-T2* Dual-Modal Imaging Probes for Tumor Diagnosis.

Visualizing Efficacy of Antineoplastic Drug Via Ratiometric Near-Infrared Fluorescence Imaging of Tumor-Associated Macrophage-Specific Nitric Oxide

Combining Photothermal Therapy‐Induced Immunogenic Cell Death and Hypoxia Relief‐Benefited M1‐Phenotype Macrophage Polarization for Cancer Immunotherapy

A Ratiometric Sers Probe for Imaging the Macrophage Phenotypes in Live Mice with Epilepsy and Brain Tumor

Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy

Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles

Differently Charged Super-Paramagnetic Iron Oxide Nanoparticles Preferentially Induced M1-Like Phenotype of Macrophages.

A covalent organic framework-derived M1 macrophage mimic nanozyme for precise tumor-targeted imaging and NIR-II photothermal catalytic chemotherapy